12890_2019_989_MOESM1_ESM.docx (78.53 kB)
MOESM1 of The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
journal contribution
posted on 2019-11-28, 04:59 authored by Kathleen Morrisroe, Wendy Stevens, Joanne Sahhar, Gene-Siew Ngian, Nava Ferdowsi, Dylan Hansen, Shreeya Patel, Catherine Hill, Janet Roddy, Jennifer Walker, Susanna Proudman, Mandana NikpourAdditional file 1: Table S1. PAH specific vasodilator therapy cost Table S2. Determinants of above median annual total healthcare cost in SSc-PAH in univariant logistic regression Table S3. Impact of PAH severity on total healthcare cost and its components in SSc-PAH